这些结果表明阿里克伦在减轻高血压合并左室肥厚患者心脏终末损伤方面，与血管紧张素受体阻滞剂的效果类似。
These findings suggest that aliskiren was as effective as an angiotensin receptor blocker in attenuating this measure of myocardial end-organ damage in hypertensive patients with LV hypertrophy.
这些结果表明阿里克伦在减轻高血压合并左室肥厚患者心脏终末损伤方面，与血管紧张素受体阻滞剂的效果类似。
These findings suggest that aliskiren was as effective as an angiotensin receptor blocker in attenuating this measure of myocardial end-organ damage in hypertensive patients with LV hypertrophy.
应用推荐